Optimization of a Protocol for Isolating Cell-free DNA From Cerebrospinal Fluid

Area of Science:

• Biochemistry
• Molecular Biology
• Clinical Diagnostics

Background:

• Standardized protocols for isolating cell-free DNA (cfDNA) from cerebrospinal fluid (CSF) are currently lacking.
• Accurate cfDNA quantification is crucial for in vitro diagnostic (IVD) applications, particularly in oncology.
• Optimizing cfDNA isolation from CSF is essential for advancing liquid biopsy techniques.

Purpose of the Study:

• To establish and optimize a cfDNA isolation protocol specifically for clinical CSF specimens.
• To compare the efficiency of column-based (CB) and magnetic bead-based (MB) cfDNA isolation methods from CSF.
• To enhance cfDNA yield and concentration for improved ctDNA detection in IVD testing.

Main Methods:

• Developed a modified cfDNA isolation protocol using artificial CSF spiked with reference cell-free tumor DNA (ctDNA).
• Compared yields of IVD-certified CB and MB isolation kits, including modifications like pre- and post-elution steps.
• Utilized droplet digital PCR (ddPCR) to assess ctDNA integrity and variant allele frequency (VAF) of the IDH1 R132C mutation.

Main Results:

• Magnetic bead-based (MB) isolation demonstrated significantly higher cfDNA yields compared to column-based (CB) isolation (P<0.0001).
• Post-isolation vacuum application effectively increased the final cfDNA concentration for both methods.
• The vacuum step had minimal impact on the integrity of the isolated cfDNA.

Conclusions:

• The developed protocol effectively maximizes CSF-ctDNA concentrations, crucial for sensitive IVD testing.
• MB isolation is superior to CB isolation for cfDNA recovery from CSF specimens.
• Optimized isolation protocols are vital for the advancement of CSF-based liquid biopsies and future clinical studies.